106 related articles for article (PubMed ID: 38754114)
1. Guideline versus clinician recommended duration of dual antiplatelet therapy following acute coronary syndrome (ANZACS-QI 78).
Rees SJ; Kerr AJ
N Z Med J; 2024 May; 137(1595):64-72. PubMed ID: 38754114
[TBL] [Abstract][Full Text] [Related]
2. [Update ESC-Guideline 2017: Dual Antiplatelet Therapy].
Massberg S; Polzin A
Dtsch Med Wochenschr; 2018 Aug; 143(15):1090-1093. PubMed ID: 30060279
[TBL] [Abstract][Full Text] [Related]
3. Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel.
Morneau KM; Reaves AB; Martin JB; Oliphant CS
J Manag Care Pharm; 2014 Feb; 20(2):187-93. PubMed ID: 24456320
[TBL] [Abstract][Full Text] [Related]
4. Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction.
Sehested TSG; Carlson N; Hansen PW; Gerds TA; Charlot MG; Torp-Pedersen C; Køber L; Gislason GH; Hlatky MA; Fosbøl EL
Eur Heart J; 2019 Jun; 40(24):1963-1970. PubMed ID: 30851041
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Guideline-Recommended Risk Score-Directed Dual Antiplatelet Therapy After 2nd-Generation Drug-Eluting Stents.
Jang JY; Lee BK; Kim JS; Shin DH; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Park KW; Gwon HC; Kim HS; Kwon HM; Jang Y
Circ J; 2020 Jan; 84(2):161-168. PubMed ID: 31839621
[TBL] [Abstract][Full Text] [Related]
6. Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome: a population-based cohort study in Catalonia (Spain).
Ribera A; Ferreira-Gonzalez I; Marsal JR; Oristrell G; Faixedas MT; Rosas A; Tizón-Marcos H; Rojas S; Labata C; Cardenas M; Homs S; Tomas-Querol C; Garcia-Picart J; Gomez-Hospital JA; Pijoan JI; Masotti M; Mauri J; Garcia Dorado D;
BMJ Open; 2019 Jul; 9(7):e028114. PubMed ID: 31340964
[TBL] [Abstract][Full Text] [Related]
7. Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease.
Krackhardt F; Waliszewski M; Kočka V; Toušek P; Janek B; Hudec M; Lozano F; Roman KG; Del Blanco BG; Mauri J; Heang TM; Ahn TH; Jeong MH; Herberger D; Tomulic V; Levy G; Sebagh L; Rischner J; Pansieri M
Cardiovasc Drugs Ther; 2020 Jun; 34(3):335-344. PubMed ID: 32212061
[TBL] [Abstract][Full Text] [Related]
8. Improving use of proton pump inhibitors with dual antiplatelet therapy in patients admitted with acute coronary syndrome.
Jinadu T; Radhakrishnan A; Fan L
BMJ Open Qual; 2022 Dec; 11(4):. PubMed ID: 36564103
[TBL] [Abstract][Full Text] [Related]
9. Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial.
Choi KH; Song YB; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Oh JH; Cho DK; Lee JB; Doh JH; Kim SH; Jeong JO; Bae JH; Kim BO; Cho JH; Suh IW; Kim DI; Park HK; Park JS; Choi WG; Lee WS; Gwon HC; Hahn JY
Circ Cardiovasc Interv; 2020 May; 13(5):e008530. PubMed ID: 32354228
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar.
Awaisu A; Hamou F; Mekideche L; El Muabby N; Mahfouz A; Mohammed S; Saad A
Int J Clin Pharm; 2016 Apr; 38(2):353-61. PubMed ID: 26749343
[TBL] [Abstract][Full Text] [Related]
11. Paired risk scores to predict ischaemic and bleeding risk twenty-eight days to one year after an acute coronary syndrome.
Kerr AJ; Choi Y; Williams MJ; Stewart RA; White HD; Devlin G; Selak V; Lee MAW; El-Jack S; Adamson PD; Fairley S; Jackson RT; Poppe K
Heart; 2023 Nov; 109(24):1827-1836. PubMed ID: 37558394
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
Vaduganathan M; Cannon CP; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Bhatt DL;
Am J Med; 2016 Sep; 129(9):1002-5. PubMed ID: 27143321
[TBL] [Abstract][Full Text] [Related]
13. International patterns of dual antiplatelet therapy duration after acute coronary syndromes.
Bueno H; Pocock S; Danchin N; Annemans L; Gregson J; Medina J; Van de Werf F
Heart; 2017 Jan; 103(2):132-138. PubMed ID: 27504002
[TBL] [Abstract][Full Text] [Related]
14. Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry.
Hoedemaker NPG; Damman P; Ottervanger JP; Dambrink JHE; Gosselink ATM; Kedhi E; Kolkman E; de Winter RJ; van 't Hof AWJ
Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):127-138. PubMed ID: 30084902
[TBL] [Abstract][Full Text] [Related]
15. Provision of gastroprotective medication and bleeding risk following acute coronary syndrome.
Badar A; Scaife J; Yan AT; Robinson SD; Zaman AG; Purcell IF; Ahmed JM; Egred M; Edwards RJ; Spyridopoulos I; Keavney BD; Bagnall AJ
J Invasive Cardiol; 2013 Aug; 25(8):397-401. PubMed ID: 23913604
[TBL] [Abstract][Full Text] [Related]
16. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial.
Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL
Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541
[TBL] [Abstract][Full Text] [Related]
17. [Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].
Che QQ; Wu Q; Liang YB; Sun RM; Lyu QW; Ma JL; Hu H; Lin X; Xu GL; Sun SG; Zhang C; Wang QY; Yu J; Bai F
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):129-140. PubMed ID: 30818941
[No Abstract] [Full Text] [Related]
18. Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials.
Verdoia M; Kedhi E; Suryapranata H; Frati G; Biondi-Zoccai G; De Luca G
J Thromb Thrombolysis; 2020 Aug; 50(2):337-354. PubMed ID: 31919736
[TBL] [Abstract][Full Text] [Related]
19. [Antiplatelet duration in the elderly patients after percutaneous coronary intervention].
Sokoloff A; Picard F; Degrell P; Varenne O
Ann Cardiol Angeiol (Paris); 2018 Dec; 67(6):411-416. PubMed ID: 30360900
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.
Marquis-Gravel G; Neely ML; Valgimigli M; Costa F; Van Klaveren D; Altner R; Bhatt DL; Armstrong PW; Fox KAA; White HD; Ohman EM; Roe MT
Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006582. PubMed ID: 32862694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]